Print Friendly, PDF & Email

NCT/Study#

NCT03033914 /

MSK16-1536

Phase I/II Of Nivolumab And A(B)VD In The Front-Line Setting For High Risk Hodgkin Lymphoma

DISEASE GROUP:
Lymphoma
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: